.
.
.
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine.
Meschi S, Matusali G, Colavita F, Lapa D, Bordi L, Puro V, Leoni BD, Galli C, Capobianchi MR, Castilletti C; INMI Covid-19 laboratory and investigation team.
.
Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing.
Xu X, Chemparathy A, Zeng L, Kempton HR, Shang S, Nakamura M, Qi LS. Xu X, et al.
.
Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.
- Gluten intolerance a significant risk factor
- Infectious disease of the uterus
- Absence of an individual specific disease